BMP7
protein-codingbone morphogenetic protein 7, the group of Bone morphogenetic proteins
Gene summary
This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer, which plays a role in bone, kidney and brown adipose tissue development. Additionally, this protein induces ectopic bone formation and may promote fracture healing in human patients. [provided by RefSeq, Jul 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~97.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0015337
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0019719
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0017771
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0019042
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0005345
Submitter: Ambry Genetics
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to BMP7 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001719.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 15 | 6 | 22 | ||
| missense | 2 | 69 | 3 | 74 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 2 | 0 | 74 | 15 | 9 | 100 |
Highest pathogenic variant AF is 0.000008054962
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001710.1 | 7 | MANE Select | |
| Ensembl | ENSP00000379204.3 | 7 | MANE Select | |
| Ensembl | ENSP00000379205.3 | 6 | Standard | |
| Ensembl | ENSP00000379205.3 | 6 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| bmp7a | Danio rerio | Structure: erythroid lineage cell Quality: absent abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- TGF-beta signaling pathway - Homo sapiens (human)
- Axon guidance - Homo sapiens (human)
- Hippo signaling pathway - Homo sapiens (human)
- Cytokine-cytokine receptor interaction - Homo sapiens (human)
- TGF-Core
Biological Process
- skeletal system development
- ossification
- metanephros development
- ureteric bud development
- mesoderm formation
Molecular Function
- cytokine activity
- transforming growth factor beta receptor binding
- protein binding
- growth factor activity
- heparin binding
Cellular Component
- extracellular region
- extracellular space
- vesicle
- collagen-containing extracellular matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000395863
- Coding exons
- 7
- Length
- 97882
- Individuals with no LoFs
- 125738
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 10
- Defined
- 125748
- p
- 0.0000398
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.78 | 190 | 273 | 0.696 | 0.0000182 | 2841 |
| Missense (PolyPhen) | 56 | 113.52 | 0.49333 | 1196 | ||
| Synonymous | 0.236 | 111 | 114 | 0.972 | 0.00000826 | 807 |
| Loss of Function | 2.90 | 5 | 18.5 | 0.271 | 9.60e-7 | 189 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00013 | 0.00012 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000055 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000045 | 0.000044 | rare |
| South Asian | 0.000068 | 0.000065 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Induces cartilage and bone formation. May be the osteoinductive factor responsible for the phenomenon of epithelial osteogenesis. Plays a role in calcium regulation and bone homeostasis.;
Recessive Scores
- pRec
- 0.673
Intolerance Scores
- LoFtool
- 0.123
- RVIS EVS
- -0.51
- RVIS percentile EVS
- 21.41
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.958
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |